These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20426385)

  • 1. ["Diet risks the energy supply to the brain" (interview by Katrin Balzer)].
    Peters A
    Pflege Z; 2010 Apr; 63(4):224-7. PubMed ID: 20426385
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term multidisciplinary therapy decreases predictors and prevalence of metabolic syndrome in obese adolescents.
    Caranti DA; Tock L; Prado WL; Siqueira KO; de Piano A; Lofrano M; Dâmaso AR; Dâmaso AR; Cristofalo DM; Lederman H; Dâmaso AR; de Mello MT; Tufik S; Dâmaso AR; Dâmaso AR
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):e11-3. PubMed ID: 17509840
    [No Abstract]   [Full Text] [Related]  

  • 3. The safety and efficacy of a controlled low-energy ('very-low-calorie') diet in the treatment of non-insulin-dependent diabetes and obesity.
    Amatruda JM; Richeson JF; Welle SL; Brodows RG; Lockwood DH
    Arch Intern Med; 1988 Apr; 148(4):873-7. PubMed ID: 3355307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients.
    Lucotti P; Setola E; Monti LD; Galluccio E; Costa S; Sandoli EP; Fermo I; Rabaiotti G; Gatti R; Piatti P
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E906-12. PubMed ID: 16772327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dietary recommendations for type 2 diabetic patients. Satiety despite weight loss].
    Stiefelhagen P
    MMW Fortschr Med; 2009 Apr; 151(18):12-4. PubMed ID: 19769064
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurobehavioral inhibition of reward-driven feeding: implications for dieting and obesity.
    Appelhans BM
    Obesity (Silver Spring); 2009 Apr; 17(4):640-7. PubMed ID: 19165160
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma ghrelin levels after two high-carbohydrate meals producing different insulin responses in patients with metabolic syndrome.
    Heinonen MV; Karhunen LJ; Chabot ED; Toppinen LK; Juntunen KS; Laaksonen DE; Siloaho M; Liukkonen KH; Herzig KH; Niskanen LK; Mykkänen HM
    Regul Pept; 2007 Feb; 138(2-3):118-25. PubMed ID: 17030069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on: "Neurobehavioral inhibition of reward-driven feeding: implications for dieting and obesity".
    Lowe MR
    Obesity (Silver Spring); 2009 Apr; 17(4):622-4. PubMed ID: 19322141
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is diet soda a healthy choice?
    Yantis MA; Hunter K
    Nursing; 2010 Nov; 40(11):67. PubMed ID: 20975439
    [No Abstract]   [Full Text] [Related]  

  • 11. Hunger and satiety as conditioned reflexes.
    Booth DA
    Res Publ Assoc Res Nerv Ment Dis; 1981; 59():143-63. PubMed ID: 7455332
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects.
    Wing RR; Marcus MD; Salata R; Epstein LH; Miaskiewicz S; Blair EH
    Arch Intern Med; 1991 Jul; 151(7):1334-40. PubMed ID: 2064484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carbohydrate reduced diet for type 2 diabetic patients. This saves on diabetes drugs].
    Wepner U
    MMW Fortschr Med; 2007 Feb; 149(5):16, 18. PubMed ID: 17632807
    [No Abstract]   [Full Text] [Related]  

  • 14. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature.
    Türkoglu C; Duman BS; Günay D; Cagatay P; Ozcan R; Büyükdevrim AS
    Obes Surg; 2003 Oct; 13(5):699-705. PubMed ID: 14627463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of insulin resistance after diet with a whole-grain based dietary product: results of a randomized, controlled cross-over study in obese subjects with elevated fasting blood glucose.
    Rave K; Roggen K; Dellweg S; Heise T; tom Dieck H
    Br J Nutr; 2007 Nov; 98(5):929-36. PubMed ID: 17562226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus.
    Watts NB; Spanheimer RG; DiGirolamo M; Gebhart SS; Musey VC; Siddiq YK; Phillips LS
    Arch Intern Med; 1990 Apr; 150(4):803-6. PubMed ID: 2327840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet and exercise in noninsulin-dependent diabetes mellitus: implications for dietitians from the NIH Consensus Development Conference.
    Wheeler ML; Delahanty L; Wylie-Rosett J
    J Am Diet Assoc; 1987 Apr; 87(4):480-5. PubMed ID: 3559008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
    Nettleton JA; Katz R
    J Am Diet Assoc; 2005 Mar; 105(3):428-40. PubMed ID: 15746832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.